Marie Skłodowska-Curie ITN: EVOluTION Phd Studentship
This post sits within the William Harvey Research Institute: http://www.whri.qmul.ac.uk/, Barts and The London School of Medicine and Dentistry, part of Queen Mary University of London. The SMD is a leading medical and dental school that offers international levels of excellence in research and teaching as well as providing clinical service for a population of unrivalled ethnic diversity in east London and the wider Thames Gateway. Further information can be found attached and at http://www.smd.qmul.ac.uk .
The William Harvey Research Institute has three core strategic themes: Inflammation, Cardiovascular and Endocrinology with a mix of basic scientists and clinicians benefitting from strong links with Bart’s and The London NHS Trust. The research ethos is linking together bench to bedside research, with recent investments into a state-of-the-art campus based QMUL Lipid Mediator Unit, Flow Facilities, Microscopy Imaging equipment.
Applications are invited for a Phd Studentship Early Stage Researcher (ESR) to work within a Marie Skłodowska-Curie Innovative Training Network (MSCA ITN) in translational pharmacology and therapeutic innovation.
The ESR appointed will work in the laboratory of Prof Amrita Ahluwalia, at the Centre for Clinical Pharmacology within the WHRI. The goal of the research project will be to establish whether Xanthine Oxidoreductase (XOR) acts as a nitrite reductase in chronic settings, evoking blood pressure lowering in hypertension with different aetiologies. A strong interest in understanding the mechanisms involved in hypertension and its associated pathologies and in development of novel therapeutics is required. The ESR will be supervised by Prof. Ahluwalia. Informal enquiries should be addressed to: firstname.lastname@example.org, or +44 20 7882 8377.
As part of the MSCA ITN scheme, there are strict *eligibility requirements*. At the time of appointment, applicants must not have resided or carried out their main activity (work, studies, etc.) in the UK for more than 12 months in the 3 years immediately before appointment under the project; AND shall also be in the first four years of their research careers at the time of appointment by the host organisation and have not been awarded a doctoral degree. For more information on MSCA ITN, please see: http://ec.europa.eu/mariecurieactions.
The post is full time and fixed term for a period of 3 years. You will be offered a salary plus mobility allowance and, if applicable, a family allowance in line with the funding body rules. Salary will be a fixed salary rate of approximately £29644.92 salary per annum and includes the single person’s mobility allowance or approximately £33059.16 salary per annum which includes the married person’s/dependents mobility allowance (depending on the EURO: sterling exchange rate and pension arrangements). Benefits include 30 days annual leave, defined benefit pension scheme and interest-free season ticket loan.
Candidates must be able to demonstrate their eligibility to work in the UK in accordance with the Immigration, Asylum and Nationality Act 2006. Where required this may include entry clearance or continued leave to remain under the Points Based Immigration Scheme.
The deadline for applications is the 18th of July 2017.
Interviews will be held on the 25th of July 2017 in London. The position will start on the 2nd October 2017.
Informal enquiries are welcome and should be addressed to: email@example.com.
Details about the EVOluTION programme can be found at http://www.qmul.ac.uk/evolution
Details about the WHRI can be found at http://www.whri.qmul.ac.uk
Queries regarding the application process should go to firstname.lastname@example.org
Application enquiries should be directed to Recruitment at email@example.com
To apply, please visit: https://webapps2.is.qmul.ac.uk/jobs/job.action?jobID=2456
Valuing Diversity & Committed to Equality
Deadline: July 18, 2017